Showing results (381-390 of 612) with videos related to

Sort By:
Pageof 62
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2021
Evaluation of short-term safety of COVID-19 vaccines in patients with multiple sclerosis from Latin AmericaRicardo Alonso, Aníbal Chertcoff, Felisa Del V Leguizamón, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 20, 2022
Cerebrospinal fluid evaluation in patients with progressive motor impairment due to critical central nervous system demyelinating lesionsBenan Barakat, Steve Messina, Shreya Nayak, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 17, 2021
Feasibility of cognitive rehabilitation in patients with advanced multiple sclerosis: A pilot studyStefanos E Prouskas, Nancy D Chiaravalloti, Neeltje Kant, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 20, 2021
Clinical features and outcomes of COVID-19 despite SARS-CoV-2 vaccination in people with multiple sclerosisDeja R Rose, Ahmad Z Mahadeen, Alise K Carlson, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 20, 2021
Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapyAudrey Rico, Laetitia Ninove, Adil Maarouf, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 21, 2022
Quantitative MRI findings indicate diffuse white matter damage in Susac SyndromeP Johnson, J K Chan, I M Vavasour, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 27, 2022
Development of an indicator of smoking status for people with multiple sclerosis in administrative dataRuth Ann Marrie, Qier Tan, Okechukwu Ekuma, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 28, 2022
Extended Interval Dosing Natalizumab and impact on neuropsychological deficits in Relapsing-Remitting Multiple SclerosisEileen J McManus, Karen M Clark, Christopher Frampton, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 26, 2019
Predictors of hospital-based multidisciplinary rehabilitation effects in persons with multiple sclerosis: a large-scale, single-centre studyElisabetta Groppo, Alessio Signori, Maria Pia Sormani, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 4, 2022
Comparing the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis: A cost-consequence analysis from a societal perspective in GermanyDominik Koeditz, Juergen Frensch, Martin Bierbaum, et al.
Pageof 62